FDA Inspection 1149752 — Vaughn, Silverberg and Associates, LLP

Vaughn, Silverberg and Associates, LLP — FEI 3003724356

The FDA completed an inspection of Vaughn, Silverberg and Associates, LLP on August 23, 2021 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Austin, TX (United States)

Citations

IDCFRDescription
1224121 CFR 1271.55(b)(4)Reasons for ineligibility on summary